The Antimelanoma Immunocytokine scFvMEL/TNF Shows Reduced Toxicity and Potent Antitumor Activity against Human Tumor Xenografts
Open Access
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- The immunocytokine scFv23/TNF sensitizes HER-2/neu–overexpressing SKBR-3 cells to tumor necrosis factor (TNF) via up-regulation of TNF receptor-1Molecular Cancer Therapeutics, 2005
- Coupling Tumor Necrosis Factor-α with αV Integrin Ligands Improves Its Antineoplastic ActivityCancer Research, 2004
- Human tumor necrosis factor-α mutant RGD-V29 (F4614) shows potent antitumor activity and reduced toxicity against human tumor xenografted nude miceCancer Letters, 2000
- Novel muteins of human tumor necrosis factor with potent antitumor activity and less lethal toxicity in miceInternational Journal of Cancer, 1995
- Efficacy of tnf‐α gene‐transduced tumor cells in treatment of established in vivo tumorInternational Journal of Cancer, 1995
- A genetically engineered single-chain FVTNF molecule possesses the anti-tumor immunoreactivity of FV as well as the cytotoxic activity of tumor necrosis factorMolecular Immunology, 1995
- Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid moleculeBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1991
- Cytostatic and Cytotoxic Effects of Recombinant Tumor Necrosis Factor-α on Sensitive Human Melanoma Cells In Vitro May Result in Selection of Cells with Enhanced Markers of MalignancyJournal of Investigative Dermatology, 1990
- Single-Chain Antigen-Binding ProteinsScience, 1988
- Analysis of the NIH Workshop Monoclonal Antibodies to Human Melanoma AntigensHybridoma, 1982